Preview

Malignant tumours

Advanced search
Fullscreen

For citations:


Semenov N.N., Fedyanin M.Yu., Zhukova L.G., Khatkov I.E., Stroyakovskii D.L., Pokataev I.A. The results of the use of immune checkpoint inhibitors (ICI) pembrolizumab and nivolumab in the first line treatment of patients with metastatic gastric cancer. The experience of the oncological service of Moscow. Malignant tumours. 2025;15(1):27–35. (In Russ.) https://doi.org/10.18027/2224-5057-2025-039

Views PDF (Rus): 103


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)